An extension was required to provide time to review additional data requested by the FDA to clarify sparsentan’s clinical benefit.

Focal segmental glomerulosclerosis (FSGS) is a rare kidney disorder that affects children and adults, and can lead to kidney failure. New findings from a team led by the University of Minnesota ...

Crews have completed the widening of a segmental fly-over bridge in Miami-Dade County—a rare construction feat and the first job of its kind in the mainland United States. Construction of the project ...

Focal segmental glomerulosclerosis (FSGS) still lacks an FDA-approved therapy, but late-breaking post hoc results from the phase III DUPLEX trial -- presented at the National Kidney Foundation Spring ...